‘The Future of Dementia Care’

The Annual Conference of the Faculty of Old Age Psychiatry will take place next month and has Professor Craig Ritchie presenting on “The Future of Dementia Care” The publicly available … Continue reading ‘The Future of Dementia Care’

Key opinion leaders and Industry: Snakes, ladders and Monopoly

Dr Margaret McCartney in her recent ‘No Holds Barred” perspective set this challenge: “Here’s a game: try and find a doctor’s conflicts of interest. Set a timer, and give yourself … Continue reading Key opinion leaders and Industry: Snakes, ladders and Monopoly

Exposure to industry promotional activity can lead to doctors recommending worse treatments for patients

This is my BMJ Rapid Response, of the 6th January 2018 to Mike Thompson, CEO of the ABPI. [Association of the British Pharmaceutical Industry] I share Mike Thompson’s disappointment in some aspects … Continue reading Exposure to industry promotional activity can lead to doctors recommending worse treatments for patients

Stifling distortions

                 

“Packaging up old myths”

Last week the Association of the British Pharmaceutical Industry (ABPI) held its Annual Conference: The Pharmaceutical Industry are concerned about an “affordability conundrum”: This BBC Report from November 2014: “Pharmaceutical Industry … Continue reading “Packaging up old myths”

“A mark of exceptional impact”

On the 26th March 2015, following a previous post by Hole Ousia, the Royal College of Psychiatrists stated that it “‏is committed to our Conflicts of Interest policy.”  This policy … Continue reading “A mark of exceptional impact”

Continuing Medical Education and its entanglement with the Pharmaceutical Industry

Yesterday I sent the e-mail (at the foot of this post) to Alex Neil, Cabinet Secretary for Health and Well-being for the Scottish Government. It should be self explanatory. My … Continue reading Continuing Medical Education and its entanglement with the Pharmaceutical Industry

Truth of an industry and the transparency of a profession

GlaxoSmithKline is fined record $3bn in US, published 3 July 2012 Reply by Dr Peter J Gordon as rapid-response to the BMJ, 10th July 2012. Truth of an industry and … Continue reading Truth of an industry and the transparency of a profession